Product: | Telaprevir | |
---|---|---|
Catalog Number: | 14848 | |
CAS Number: | 402957-28-2 | |
Synonyms: |
(1S,3aR,6aS)-2-[(2S)-2-[[(2S)-2-Cyclohexyl-2-(pyrazine-2-carbonylamino)acetyl]amino]-3,3-dimethylbutanoyl]-N-[(3S)-1-(cyclopropylamino)-1,2-dioxohexan-3-yl]-3,3a,4,5,6,6a-hexahydro-1H-cyclopenta[c]pyrrole-1-carboxamide; VX-950 |
|
Pricing: |
|
|
Structure: | ||
Category: | Protein Kinase Inhibitors and Activators | |
Literature References: |
^ Lin C, Kwong AD, Perni RB (March 2006). "Discovery and development of VX-950, a novel, covalent, and reversible inhibitor of hepatitis C virus NS3.4A serine protease". Infect Disord Drug Targets 6 (1): 3–16. doi:10.2174/187152606776056706. PMID 16787300. ;McHutchison JG, Manns MP, Muir AJ, et al. (2010). "Telaprevir for previously treated chronic HCV infection". N Engl J Med 362 (14): 1292–303. doi:10.1056/NEJMoa0908014. PMID 20375406. http://content.nejm.org/cgi/pmidlookup?view=short&pmid=20375406&promo=ONFLNS19.
|
|
MSDS: | ||
Description: |
Anti-viral drug, protease inhibitor. |